oppn parties Covaxin To Be Produced By Other Vaccine Manufacturers

News Snippets

  • ED has issued a showcause notice to Xiaomi India, two of its senior officials and three foreign banks for FEMA violations to the tune of Rs 5551cr
  • India's South-West coast to be hit by very severe Cyclone Biparjoy which will intensify in the next 36 hours
  • PM Modi pays tributes to Birsa Munda on his death anniversary
  • CBI forms SIT to probe violence in Manipur
  • Coal mine collapses in Dhanbad, three dead and scores feared trapped
  • Death threats for Sharad Pawar & Sanjay Raut, probe ordered and security tightened
  • Akhilesh Yadav says law & order situation is out of control in UP
  • Diesel (8.22 million tonnes), petrol (3.35 million tonnes) consumption hits a new high in May
  • Congress' Kamal Nath Sandesh Yatra will begin in Madhya Pradesh on June 15
  • Congress rubbishes reports of Sachin Pilot starting a new outfit, says they are just rumours
  • Delhi Police take women wrestler who had complained against WFI chief B B S Singh to federation office
  • IT minister Rajeev Chandrasekhar says government will regulate the AI space to keep digital citizens safe
  • Stocks turn negative on Friday: Sensex loses 223 points to 62625 and Nifty 71 points to 18563
  • WTC final: If India can keep the Aussie lead to below 400, they can still make a match of it
  • WTC final: Indian bowlers get their act right in the second innings but Aussies race to a lead of nearly 300 for the loss of 4 wickets
Fresh flare-up in Manipur as 3 persons were shot dead in a Kuki village inKangpopki district
oppn parties
Covaxin To Be Produced By Other Vaccine Manufacturers

By Linus Garg
First publised on 2021-05-14 01:29:06

About the Author

Sunil Garodia Linus tackles things head-on. He takes sides in his analysis and it fits excellently with our editorial policy. No 'maybe's' and 'allegedly' for him, only things in black and white.

Nearly a month after Prime Minister Modi first talked about using the entire vaccine manufacturing capacity in the country to produce the Covid vaccines and former prime minister and Congress leader Dr Manmohan Singh urged the government to invoke compulsory licensing provisions to allow all capable manufacturers to produce the vaccines, the government has invited all vaccine manufacturers in India to produce the indigenously developed (by ICMR and Bharat Biotech) Covaxin that is currently being made only by Bharat Biotech. NITI Aayog member Dr V K Paul said that Bharat Biotech has agreed to this arrangement.

This is a good move as it will help the government procure more doses from additional and captive sources at an attractive price. But it is regrettable that it took the government one month to take this decision. Under normal circumstances, such delays are part and parcel of both governance and corporate negotiations. But when there is a pandemic situation, the Disaster Management Act is in force and vaccines are in short supply threatening to derail the vaccine drive, one thinks decisions need to be taken on war footing. Such delays cannot be condoned in these troubled times.

But there is a stumbling block in the process as not all vaccine manufacturers in India have a BSL3 (Biosafety Level 3) lab which is necessary to inactivate a live virus in order to produce the Covid vaccines. The government must help those vaccine manufacturers who do not have this facility to get the lab up and running as fast as possible. It must provide them with funds and if import of equipment is required, it must allow and facilitate that. It must also assist them in getting the imported raw materials and provide them advance payments to fund their working capital requirements. Hopefully, once these manufacturers start production in full, there will be no vaccine shortage in India.